United Kingdom· GB-APID-45485611000001106
Tuzulby 40mg prolonged-release chewable tablets
A methylphenidate product containing methylphenidate, registered in United Kingdom by Neuraxpharm UK Ltd. The same ATC class is registered in 18 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Methylphenidate is registered in 18 of 19 countries.
Countries holding a registration under ATC N06BA04 (methylphenidate), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Methylphenidate · ATC N06BA04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methylphenidate costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.56 in France to $1.87 in Switzerland — a ×3.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Methylphenidate · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.87
- IT Italy$0.68
- US United States$0.56 (acquisition cost)
- FR France$0.56
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Methylphenidate
- Manufacturer
- Neuraxpharm UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- N06BA04
- ATC class
- Methylphenidate
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin8436027473992
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
196 interactions on record for methylphenidate.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylphenidate · interactions on record
196 records
- 12 severe
- 45 moderate
- 3 minor
- 128 info
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- CocaineN01BC01severe
8 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06BA04
Methylphenidate, as other registers publish it.
- Germany5 Mg, MedikinetMedice Arzneimittel Pütter Gmbh & Co. Kg
- Germany50 Mg, Medikinet AdultMedice Pharma Gmbh & Co. Kg
- CanadaACT METHYLPHENIDATE ERTEVA CANADA LIMITED
- CanadaACT METHYLPHENIDATE ERTEVA CANADA LIMITED
- CanadaACT METHYLPHENIDATE ERTEVA CANADA LIMITED
- CanadaACT METHYLPHENIDATE ERTEVA CANADA LIMITED
- PolandAdehaderHumantis GmbH
- PolandAdehaderHumantis GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f7e5cf7-6cae-42f9-903c-d3684520fcf0 GET /v1/drugs/6f7e5cf7-6cae-42f9-903c-d3684520fcf0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45485611000001106",
"desc": "Tuzulby 40mg prolonged-release chewable tablets (Neuraxpharm UK Ltd)",
"form": "Prolonged-release chewable tablet",
"vpid": "45489611000001109",
"source": "dmd",
"vtm_id": "776752004",
"strength": "40 mg",
"substance": "Methylphenidate",
"ingredient": "Methylphenidate hydrochloride",
"supplier_code": "37898411000001108"
}See everything about methylphenidate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.